Posted May 04, 2009 in Blog, Botox and Facial Fillers, Plastic Surgery in the News, Uncategorized
There is a new wrinkle fighter in town. The FDA has approved Medicis’ botulium toxin drug, Dysport. They plan to release the drug for public use within the next two months. This marks the first time that Botox giant Allergan will have competition in the wrinkle, anti-aging market in the U.S. More news to follow.
